U.S./EU device MRA implementation by FDA will rely on outside organizations.
This article was originally published in The Gray Sheet
Executive Summary
U.S./EU MRA IMPLEMENTATION BY NON-FDA U.S. ASSESSMENT BODIES PLANNED by the agency, FDA staffers say. Given its resource limitations, FDA is seeking to outsource the European Union CE mark premarket evaluations and facility inspections for conformance to the EU's EN 46000 series quality systems standards mandated by the June device mutual recognition agreement (MRA).
You may also be interested in...
Rep. DeLauro Tries To Block FDA Outsourcing Of Antibiotic Label Updating
FDA's efforts to rely on outside support to carry out its mission have again met with resistance from House Appropriations Subcommittee Chair Rosa DeLauro, D-Conn., who is arguably the agency's most powerful public benefactor
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.